HOUSTON (PRWEB)
October 15, 2019
Representatives with MyBioGate announced that they are now inviting event and media partners for China Focus@Europe Hamburg to be held November 10 in Hamburg, Germany.
“We could not build the best partnering platform without our partners. We look forward to building a mutually beneficial partnership with our partners. If you are interested in becoming a partner, please don’t hesitate to contact us,” said Miao Guo, Vice President of Operations and spokesperson for MyBioGate.
Guo went on to highlight that China Focus@Euorpe Hamburg will bring together investors, pharma leaders, and innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations.
Guo noted that the event would feature keynote speech, panel discussions, Chinese companies showcase, 1-on-1 meetings, and company presentations (Pitch & Match).
MyBioGate had partnered with several companies for its events in the past, such as Bio Club, EBD Group, AZ Bio, Vienna BioCenter, BioHouston, and SinoHealth, etc.
“The pharma market in China grew to about Rmb1,558bn (US$226bn) in 2018, at a CAGR of 10% in 2013-18, becoming the 2nd largest pharma market in the world,” Guo highlighted, before adding, “as the youngest member of ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), China joined with the least experience but holding the promise to bring domestic clinical trials to world standard and open its market. There will be new revenues for innovative therapeutics and more business development opportunities for global players. The current U.S.-China relationship and CFIUS regulations in the U.S. derived interest from some Chinese investors to the European market.”
The event will feature speakers such as Stephen Sunderland, Partner, L.E.K. Consulting;Sebastian Gensior, Founder, Sino-European Pharma Forum (SEPF); Managing Director, Global Health Access Solutions; James Huang, Managing Partner, KPCB China, and more to be announced soon.
Guo also highlighted that Forum Admissions at the event are available at €1184, and Group discounts are available for 3 or more attendees. Company presentations (Pitch & Match) also has a €500 off for the first 5 registrants. Send inquiry to info (at) mybiogate (dot) com for more details.
For more information, please visit https://events.mybiogate.com/europe/about-china-focus/ https://events.mybiogate.com/europe/
About China Focus
CHINA FOCUS is a one-of-a-kind partnering forum with a mission of connecting essential players and resources in the life science and healthcare ecosystem between China and the rest of the world. It brings together investors, pharma leaders, and innovators around the globe for an exclusive partnering event designed to inspire, inform, and foster cross-border investment and collaboration.
Since 2018, CHINA FOCUS has been successfully held in San Francisco, Philadelphia, Boston, and Vienna, attracting more than 600 companies and 800 executives worldwide. It has become a name brand and the go-to event for cross-border partnership between China and the rest of the world.
Contact Details:
Feier ChenManager of Marketing
7707 Fannin Street
Ste. 200
Houston, TX 77054
United States
Phone: (832) 497-2220
Email: feier.chen (at) mybiogate (dot) com
Source: MyBioGate Inc. (event.mybiogate.com)
Share article on social media or email: